A proteomic approach to paclitaxel chemoresistance in ovarian cancer cell lines
- 28 February 2009
- journal article
- Published by Elsevier BV in Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
- Vol. 1794 (2), 225-236
- https://doi.org/10.1016/j.bbapap.2008.09.017
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Application of 2-dimensional difference gel electrophoresis (2D-DIGE) to the study of thrombin-activated human platelet secretomePlatelets, 2008
- Comparative proteome analysis of human epithelial ovarian cancerProteome Science, 2007
- The role of galectin-3 in cancer drug resistanceDrug Resistance Updates, 2007
- Identification of Platinum-Resistance Associated Proteins through Proteomic Analysis of Human Ovarian Cancer Cells and Their Platinum-Resistant SublinesJournal of Proteome Research, 2006
- E3 Ubiquitin Ligases as Cancer Targets and BiomarkersNeoplasia, 2006
- Modulation of IMPDH2, survivin, topoisomerase I and vimentin increases sensitivity to methotrexate in HT29 human colon cancer cellsThe FEBS Journal, 2005
- A proteomic approach to cisplatin resistance in the cervix squamous cell carcinoma cell line A431Proteomics, 2004
- MGr1-Ag is associated with multidrug-resistant phenotype of gastric cancer cellsGastric Cancer, 2002
- Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes.JCI Insight, 1997
- Difference gel electrophoresis. A single gel method for detecting changes in protein extractsElectrophoresis, 1997